DEUTSCHE BANK AG\ - WUXI PHARMATECH CAYMAN INC ownership

WUXI PHARMATECH CAYMAN INC's ticker is WX and the CUSIP is 929352102. A total of 164 filers reported holding WUXI PHARMATECH CAYMAN INC in Q4 2013. The put-call ratio across all filers is 0.55 and the average weighting 0.6%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of WUXI PHARMATECH CAYMAN INC
ValueSharesWeighting
Q3 2015$1,761,000
-67.1%
40,795
-67.8%
0.00%
-66.7%
Q2 2015$5,354,000
-1.9%
126,742
-9.9%
0.00%0.0%
Q1 2015$5,455,000
+56.3%
140,706
+35.7%
0.00%
+50.0%
Q4 2014$3,489,000
-27.4%
103,726
-24.5%
0.00%
-33.3%
Q3 2014$4,809,000
-18.4%
137,381
-23.4%
0.00%
-25.0%
Q2 2014$5,893,000
+16.6%
179,397
+30.7%
0.00%0.0%
Q1 2014$5,055,000
+24.1%
137,223
+29.3%
0.00%
+33.3%
Q4 2013$4,072,000
+82.5%
106,134
+30.2%
0.00%
+50.0%
Q3 2013$2,231,00081,4900.00%
Other shareholders
WUXI PHARMATECH CAYMAN INC shareholders Q4 2013
NameSharesValueWeighting ↓
Coupland Cardiff Asset Management LLP 449,361$15,737,00015.66%
Sloane Robinson LLP 120,000$4,202,0006.01%
Black Creek Investment Management Inc. 869,173$30,438,0003.50%
Grandeur Peak Global Advisors, LLC 358,385$12,551,0003.05%
THOMAS WHITE INTERNATIONAL LTD 538,212$18,848,0002.73%
ROSENBLUM SILVERMAN SUTTON S F INC /CA 88,460$3,098,0001.39%
Granite Point Capital Management, L.P. 70,000$2,451,0001.22%
COMMONWEALTH BANK OF AUSTRALIA 2,626,749$91,989,0001.19%
Apex Capital Management 1,048,531$36,720,0001.11%
Pier Capital, LLC 196,369$6,877,0001.10%
View complete list of WUXI PHARMATECH CAYMAN INC shareholders